likewise been in and out over last 2 years. Tends to rise a...

likewise been in and out over last 2 years. Tends to rise a little on good news and then fall back even further, although 17c seems to be as far as she falls.

Very much an udervalued company, has great potential with both oncolytic viruses and CBio. Long term hold but too much else going on the leave capital waiting for the never never.

I do not hold.